Next virus could be more lethal, warns AstraZeneca vaccine creator

The scientist behind the creation of the Oxford/AstraZeneca vaccine, administered in India as Covishield to protect against COVID-19, on Monday warned that the next virus to hit humankind may be......

Will govt have Rs 80,000 cr for covid vaccine: SII CEO

Adar Poonawalla, Chief Executive Officer of Serum Institute of India which is producing the potential coronavirus vaccine developed by Oxford University, asked on Saturday if the government......

AstraZeneca's vaccine reaches phase 3 clinical trials: Trump

United States President Donald Trump has announced that the vaccine for coronavirus being developed by AstraZeneca has reached phase three clinical trials in the country and is very close to being......

2 volunteers who were given Oxford vaccine doing fine

Vital health parameters of the two volunteers, who have been administered the Oxford COVID-19 vaccine candidate at a medical college in Pune as part of the phase II clinical trial, are normal, a......

Financial crisis, legal boom

The mailboxes of Fannie Mae, Freddie Mac, AIG and Lehman Brothers are filling up with subpoenas demanding that the humbled institutions hand over vast stores of data, documents and electronic......

'Hold on to frontline stocks'

Duringthe weekly money chat with Pranav Sanghavi on Tuesday, questions revolved around which stocks to hold on toin a market which is highly unpredictable.Like always, Sanghavi was quickand precise......